Dr. Goenka is board-certified in radiation oncology and physics and has extensive experience with proton radiotherapy, intensity modulated radiation therapy, stereotactic body radiation therapy and brachytherapy applications.He received his medical degree at Johns Hopkins University and completed his post graduate training at Memorial Sloan-Kettering Cancer Center. He specializes in the treatment of cancers of all subsites, including brain, head and neck, lung, breast, esophageal, colorectal/anal, prostate, and gynecological malignancies.Dr. Goenka is the recipient of several leadership awards, has published numerous articles and abstracts in national and international journals and has participated as a guest speaker internationally. He holds memberships at the American Medical Association, American Societyfor Therapeutic Radiology and Oncology, and American Association of Physicians of Indian Origin among others and is actively involved in Community Outreach programs. Dr. Goenka is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Oligodendroglioma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Gamma Knife Radiosurgery, and Gastrostomy.

Deborah Gruber is a Neurologist in Lake Success, New York. Dr. Gruber is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). Her top areas of expertise are Glioblastoma, Glioma, Astrocytoma, and Gliomatosis Cerebri.

Samuel Singer is a Neurologist in Lake Success, New York. Dr. Singer is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Astrocytoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Bone Marrow Aspiration, and Tissue Biopsy.

"Michael Schulder, MD, is the vice chair of neurosurgery at North Shore University Hospital and Long Island Jewish Medical Center. He is also the director of the Brain Tumor Center at the Institute for Neurology and Neurosurgery-which treats more than 600 patients annually-and co-director of the Center for Stereotactic Radiosurgery, where his team offers the latest treatment technologies. His research focuses on improving methods of image guidance for brain tumor surgery, and on new techniques for radiosurgery.""I've always been fascinated by the workings of the brain and how it gives rise to our thoughts, memories and personalities in ways that aren't fully understood,"" Dr. Schulder says. He attended medical school at Columbia University College of Physicians and Surgeons, and completed his residency in neurological surgery at the Albert Einstein College of Medicine. Dr. Schulder also trained in stereotactic neuro-oncology at the University of Florida and the Brigham and Women's Hospital.Dr. Schulder works with neuro-oncologists, radiation oncologists and other neurosurgeons to create evidence-based treatment plans. ""We offer close multidisciplinary collaboration to help avoid delay in seeing patients,"" he says. The team strives to offer minimally invasive treatments as often as possible.With a keen interest in neurosurgical image guidance-the use of real-time images of the brain to make procedures safer and more precise-Dr. Schulder is studying the next generation of intraoperative MRI. He runs a brain tumor clinical trials program, giving his patients ready access to innovative approaches to care. While performing complex neurosurgery is one of the most satisfying parts of Dr. Schulder's job, ""empathizing with patients and their families throughout treatment is equally fulfilling,"" he says.In addition to treating brain tumors, Dr. Schulder performs functional neurosurgery to manage pain conditions like trigeminal neuralgia, and movement disorders including essential tremor and Parkinson's disease. He is the program director of neurosurgical residency training at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Schulder is active in organized neurosurgery, where among other offices he is past president of the World Society for Stereotactic and Functional Neurosurgery, director-at-large of the American Association of Neurological Surgeons, and historian of the American Academy Neurological Surgery.". Dr. Schulder is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Astrocytoma, Glioblastoma, Brain Tumor, Gamma Knife Radiosurgery, and Awake Craniotomy.

Adilia Hormigo, MD, PhD, is Leader, Neuro-Oncology Program, Co-Leader, Neuro-Oncology Multidisciplinary Disease Team and Professor, Hematology-Oncology, Neurosurgery, and Microbiology & Immunology at Montefiore Einstein. She is also a member of the Cancer Therapeutics Program. Her clinical expertise is the treatment of malignancies of the central nervous system and neurologic complications of cancer. Dr. Hormigo is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Myringotomy.

David Chalif is a Neurosurgery provider in Westbury, New York. Dr. Chalif is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Brain Aneurysm, Apoplexy, Subarachnoid Hemorrhage, Craniectomy, and Awake Craniotomy.

Jeffrey Bruce is a Neurosurgery provider in New York, New York. Dr. Bruce is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, Gamma Knife Radiosurgery, and Awake Craniotomy.

Eli Diamond is a Neurologist in New York, New York. Dr. Diamond is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Erdheim-Chester Disease, Glioblastoma, Astrocytoma, Brain Tumor, and Awake Craniotomy.

Christian Grommes is a Neurologist in New York, New York. Dr. Grommes is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Primary Lymphoma of the Brain, Brain Tumor, Glioma, Vitrectomy, and Bone Marrow Aspiration.

Sang Sim is an Internal Medicine specialist and a Radiation Oncologist in New Hyde Park, New York. Dr. Sim is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Laryngeal Cancer, and Endometrial Cancer.

Assistant Professor of Radiation MedicineThe Center for Head & Neck OncologyNorthShore-LIJ-Stereotactic-Radiation-CenterHofstra North Shore- LIJ School of Medicine. Dr. Ghaly is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Laryngeal Cancer, Adenoid Cystic Carcinoma, Teratocarcinosarcoma, and Olfactory Neuroblastoma.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

David Friedman is a Neurologist in Mineola, New York. Dr. Friedman is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Seizures, Generalized Tonic-Clonic Seizure, Memory Loss, and Autosomal Dominant Partial Epilepsy with Auditory Features.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Anal Cancer, Laryngeal Cancer, Throat Cancer, and Cervical Cancer.

Madhur Garg earned his medical degree at King George’s Medical College and completed his residency in radiation oncology at Rush-Presbyterian-St. Luke’s Hospital in Chicago and Montefiore in New York City. He also completed a specialized fellowship at Wayne State University in Detroit. Dr. Garg is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Cervical Cancer, Prostate Cancer, Acoustic Neuroma, and Schwannoma.

Keyur Mehta is a Radiation Oncologist in Bronx, New York. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Breast Cancer, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Elizabeth Fontana is a Neurosurgery provider in Kew Gardens, New York. Dr. Fontana is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). Her top areas of expertise are Subdural Hematoma, Chronic Subdural Hematoma, Delirium, Gastrostomy, and Awake Craniotomy.

Philip Ragone is a Neuromusculoskeletal Medicine specialist and a Neurologist in Great Neck, New York. Dr. Ragone is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Parkinson's Disease, Serotonin Syndrome, Movement Disorders, and Headache.

Jung-min Kim is a Neurologist in Manhasset, New York. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). Her top areas of expertise are Subarachnoid Hemorrhage, Stroke, Cerebral Arteriovenous Malformation, and Apoplexy.